Pharmaceutical sector: alleged discounts offered on a product

An investigation into a suspected breach of competition law related to discounts offered for a pharmaceutical product, under Chapter II CA98 and Article 102 TFEU.

Case timetable

Date Action
March 2017 (estimate) Decision on next phase of the investigation in light of evidence received to date
December 2016 to March 2017 (estimate) Further information gathering and analysis of information requests
November 2016 Decision to proceed with the investigation
June to November 2016 Further investigation including further information requests
June 2016 Decision to proceed with the investigation
December 2015 to June 2016 Initial investigation: information gathering, including issuance of formal or informal information requests and party’s responses
1 December 2015 Investigation opened

Notes

  • The investigation is under Chapter II of the Competition Act 1998 (CA98) and Article 102 Treaty on the Functioning of the European Union (TFEU).
  • Changes to the timing of original entries in the case timetable will be made where the estimated timing in the original timetable changes.
  • The Competition and Markets Authority (CMA) has not reached a view as to whether there is sufficient evidence of an infringement of competition law for it to issue a statement of objections to any of the parties under investigation. Not all cases result in the CMA issuing a statement of objections.
  • As a result, it would not be appropriate at present to include any further estimates of the timing of any later investigative steps at this stage.

Contacts

Assistant project director

Neil Maxey (020 3738 6956, neil.maxey@cma.gsi.gov.uk)

Project director

George Lusty (020 3738 6702, george.lusty@cma.gsi.gov.uk)

Senior responsible officer

Michael Grenfell (020 3738 6134, michael.grenfell@cma.gsi.gov.uk)

Help us improve GOV.UK

Don’t include personal or financial information like your National Insurance number or credit card details.